Statins and congestive heart failure.

Current Atherosclerosis Reports
Jennifer Martin

Abstract

Despite many post hoc analyses of cardiovascular databases in recent years suggesting a benefit of statins in the prevention and treatment of congestive heart failure (HF), a prospective study of statin therapy on two clinically relevant end points--HF morbidity and survival--had not been reported until 2007. However, a large-scale prospective trial, Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA), has just reported its primary results. These results somewhat surprisingly show no survival benefit in a group of patients with ischemic systolic HF given low-dose rosuvastatin. In addition to this uncertainty generated by the results of CORONA, there remains additional uncertainty in the existing, predominantly retrospective data on statins because of the potential bias in study designs, use of post hoc subgroup analyses, and lack of mechanistic data. This review critically evaluates the recent literature in this area.

References

Jan 1, 1994·Annual Review of Immunology·P A Baeuerle, T Henkel
Oct 1, 1993·Journal of the American College of Cardiology·J S Floras
Oct 19, 1996·Lancet·C J VaughanB M Buckley
Jul 21, 1999·Kidney International. Supplement·T YokotaN Tajima
Jun 13, 2000·Circulation Research·P M Kang, S Izumo
Oct 19, 2000·Lancet·M RauchhausS D Anker
Oct 9, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tamami OkamotoZenji Makita
Dec 24, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jennifer Martin, Henry Krum
Jul 25, 2003·Journal of Molecular and Cellular Cardiology·Hiroshi HasegawaIssei Komuro
Sep 4, 2003·Circulation·Mónica RupérezMarta Ruiz-Ortega
Sep 12, 2003·The American Journal of Medicine·Graziano OnderRoberto Bernabei
Dec 10, 2003·Journal of the American College of Cardiology·Mathias RauchhausStefan D Anker
Feb 21, 2004·Journal of the American College of Cardiology·Tamara B HorwichGregg C Fonarow
Apr 28, 2004·The American Journal of Cardiology·Dariush MozaffarianWayne C Levy
Oct 19, 2004·Journal of the American College of Cardiology·Justin EzekowitzUNKNOWN APPROACH Investigators
Jan 12, 2005·Archives of Internal Medicine·Joel G RayJack V Tu
Feb 8, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Nancy A MasonEric W Young
Feb 22, 2005·Atherosclerosis·Christopher H StreyChristopher M Frampton
Jun 25, 2005·International Journal of Cardiology·R Scott WrightAllan S Jaffe
Sep 22, 2005·Clinical and Experimental Pharmacology & Physiology·Jennifer MartinHenry Krum
Jan 18, 2006·Journal of the American College of Cardiology·Srikanth SolaBobby V Khan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.